Table 1.

Characteristics of study participants diagnosed with brain tumours

VariableParticipants (n = 39)
n (%)
Age at interview (mean age = 53 years, range = 22–74)
  21–4010 (26)
  41–6015 (38)
  ≥6114 (36)
Sex
  Male21 (54)
  Female18 (46)
Region of England
  Eastern30 (77)
  North Western9 (23)
Patient interval (first symptom to first presentation)a
  <7 days5 (13)
  1–4 weeks3 (8)
  1–6 months10 (26)
  7–12 months11 (28)
  >12 months10 (26)
Diagnostic interval (first presentation to diagnosis)a
  <7 days1 (3)
  1–4 weeks16 (41)
  1–6 months15 (38)
  7–12 months5 (13)
  >12 months2 (5)
Reported consultations with GPs in primary care
  07 (18)
  115 (38)
  29 (23)
  ≥38 (21)
Reported consultations with emergency care
  Emergency only (no contact with GP)7 (18)
  Emergency care with contact with GP
  • GP contact before emergency care14 (36)
  • GP contact after emergency care1 (3)
  • GP contact before and after emergency care5 (13)
  No emergency care12 (31)
Tumour type
  Diffuse astrocytoma5 (13)
  Anaplastic astrocytoma4 (10)
  Oligodendroglioma2 (5)
  Anaplastic oligodendroglioma2 (5)
  Glioblastoma22 (56)
  Other astrocytic tumours2 (5)
  Unknown2 (5)
Tumour location
  Frontal (including frontoparietal × 2)20 (51)
  Temporal10 (26)
  Parietal (including parieno-occipital × 2)4 (10)
  Occipital2 (5)
  Other (thalamus × 1, tempero-insula × 1, N/A × 1)3 (8)
WHO gradeb
  Low grade: II8 (21)
  High grade: III/IV7/22 (18/56)
  Ungraded2 (5)
  • a Participant account, not confirmed from clinical records.

  • b Brain tumours are graded by the World Health Organization (WHO) from 1 −4, according to how they behave. Tumours graded 1 and 2 are slow growing, whereas tumours graded 3 and 4 are fast-growing, more aggressive tumours. N/A = not applicable.